Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017808 · ClinicalTrials.gov registry record
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 100
- Enrollment target
NCT02017808: Completed study, sponsored by University at Buffalo.
NCT02017808 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02017808 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective, observational, single-blinded, longitudinal, 24-month OCT study of the evolution of axonal loss, as evidenced by loss of RNFLT and TMV, in RRMS patients treated with GA and in healthy controls.
Primary Outcome
Participants will have an OCT retinal health will be determined by degree of axonal loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-12 |
What the finished NCT02017808 record still lists
NCT02017808 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02017808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02017808 about?
NCT02017808 is a clinical study titled "Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months". This is a prospective, observational, single-blinded, longitudinal, 24-month OCT study of the evolution of axonal loss, as evidenced by loss of RNFLT and TMV, in RRMS patients treated with GA and in healthy controls.
What is the current status of trial NCT02017808?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-02. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT02017808?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia